BioMed Research International / 2015 / Article / Fig 4

Research Article

Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer

Figure 4

Specificity and sensitivity of tenascin-X in classifying ovarian cancer. Tenascin-X concentrations ranging from 0 to 400 ng/mL were applied to healthy, benign ovarian, and cancerous ovarian samples and classified as cancerous or healthy. Based on the number of true positives, true negatives, false positives, and false negatives, specificity and sensitivity were calculated as 0.87 and 0.82, respectively, with a cutoff value at 40 ng/mL.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.